10x Genomics宣布与 Bruker达成专利诉讼和解协议10x Genomics Announces Patent Litigation Settlement Agreement with Bruker

动脉网2025-05-15

PLEASANTON, Calif.加利福尼亚州普莱森顿,，May 14, 20252025年5月14日/PRNewswire/ --/PRNewswire/ --10x Genomics, Inc.10x Genomics公司(Nasdaq:（纳斯达克：TXG交易组), a leader in single cell and spatial biology, today announced ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2535883768?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-05-15 04:05","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2535883768","market":"us","top_or_hot":-1,"title":"10x Genomics宣布与 Bruker达成专利诉讼和解协议10x Genomics Announces Patent Litigation Settlement Agreement with Bruker","media":"动脉网","content":"<div>\n<p>PLEASANTON, Calif.加利福尼亚州普莱森顿,，May 14, 20252025年5月14日/PRNewswire/ --/PRNewswire/ --10x Genomics, Inc.10x Genomics公司(Nasdaq:（纳斯达克：TXG交易组), a leader in single cell and spatial biology, today announced ...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505150505149759d4ce&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>10x Genomics宣布与 Bruker达成专利诉讼和解协议10x Genomics Announces Patent Litigation Settlement Agreement with Bruker</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n10x Genomics宣布与 Bruker达成专利诉讼和解协议10x Genomics Announces Patent Litigation Settlement Agreement with Bruker\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-15 04:05 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505150505149759d4ce&s=b><strong>动脉网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>PLEASANTON, Calif.加利福尼亚州普莱森顿,，May 14, 20252025年5月14日/PRNewswire/ --/PRNewswire/ --10x Genomics, Inc.10x Genomics公司(Nasdaq:（纳斯达克：TXG交易组), a leader in single cell and spatial biology, today announced ...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505150505149759d4ce&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1861559042.SGD","symbol_name":"日兴方舟颠覆性创新基金B SGD","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505150505149759d4ce&s=b","article_id":"2535883768","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505150505149759d4ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2535883768","pubTimestamp":1747253100,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"作为和解的一部分，10x 预计布鲁克将支付$68 million6800万美元in equal quarterly installments between the third quarter of 2025 and the second quarter of 2026, as well as ongoing royalties on sales of its spatial biology products through the life of the licensed patents.在2025年第三季度至2026年第二季度期间分等额季度分期付款，以及在其空间生物学产品的销售上支付授权专利有效期内的持续版税。The settlement includes global patent cross-licenses and a complete withdrawal of all legal proceedings, including those in和解协议包括全球专利交叉许可，并完全撤回所有法律诉讼，包括那些在the United States美国,，Germany德国and before the European Unified Patent Court.并在欧洲统一专利法院之前。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU1861559042.SGD":"日兴方舟颠覆性创新基金B SGD","BK4588":"碎股","LU1861558580.USD":"日兴方舟颠覆性创新基金B","BK4585":"ETF&股票定投概念","BK4548":"巴美列捷福持仓","BK4121":"生命科学工具和服务","TXG":"10x Genomics, Inc."},"translate_title":"10x Genomics Announces Patent Litigation Settlement Agreement with Bruker 10x Genomics Announces Patent Litigation Settlement Agreement with Bruker","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TXG":0.9},"content_text":"PLEASANTON, Calif.加利福尼亚州普莱森顿,，May 14, 20252025年5月14日/PRNewswire/ --/PRNewswire/ --10x Genomics, Inc.10x Genomics公司(Nasdaq:（纳斯达克：TXG交易组), a leader in single cell and spatial biology, today announced that it has reached a settlement agreement with Bruker Corporation, successfully resolving all outstanding worldwide patent litigation and disputes between the two companies. As part of the settlement, 10x expects that Bruker will pay），单细胞和空间生物学领域的领导者，今天宣布已与布鲁克公司达成和解协议，成功解决了两家公司之间所有未决的全球专利诉讼和纠纷。作为和解的一部分，10x 预计布鲁克将支付$68 million6800万美元in equal quarterly installments between the third quarter of 2025 and the second quarter of 2026, as well as ongoing royalties on sales of its spatial biology products through the life of the licensed patents.在2025年第三季度至2026年第二季度期间分等额季度分期付款，以及在其空间生物学产品的销售上支付授权专利有效期内的持续版税。'At 10x, we've always believed that bold, original science must be protected, not just for the benefit of a company, but for the entire scientific ecosystem,' said Serge Saxonov, CEO of 10x Genomics. 'It is our responsibility to defend our intellectual property to fuel innovations that will advance science and human health.“在10x，我们一直相信必须保护大胆、原创的科学，这不仅是为了公司的利益，也是为了整个科学生态系统。” 10x Genomics首席执行官Serge Saxonov表示，“我们有责任捍卫我们的知识产权，以推动科学和人类健康进步的创新。”We are very happy with the outcome and its validation of our strategy. It reinforces our deep commitment to innovation, bringing great products to market and supporting our customers every step of the way.'.我们对这一结果及其对我们战略的验证感到非常高兴。它进一步坚定了我们对创新的深厚承诺，将优秀的产品推向市场，并在每一步都全力支持我们的客户。Eric Whitaker埃里克·惠塔克, Chief Legal Officer added，首席法律官补充道,，'This settlement really demonstrates the value of 10x's broad intellectual property portfolio and the fundamental importance of those inventions for spatial biology. We're pleased to conclude these matters on strong terms that support our mission and allow us to continue to invest in future breakthroughs.'.“此次和解真正展示了10x广泛的知识产权组合的价值，以及这些发明对空间生物学的根本重要性。我们很高兴以强有力的方式了结这些事项，这支持了我们的使命，并使我们能够继续投资于未来的突破。”The settlement includes global patent cross-licenses and a complete withdrawal of all legal proceedings, including those in和解协议包括全球专利交叉许可，并完全撤回所有法律诉讼，包括那些在the United States美国,，Germany德国and before the European Unified Patent Court.并在欧洲统一专利法院之前。About 10x Genomics关于10x Genomics10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated solutions include instruments, consumables and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology.10x Genomics是一家生命科学技术公司，致力于开发加速生物研究和促进人类健康的产品。我们的集成解决方案包括用于单细胞和空间生物学的仪器、耗材和软件，这些方案帮助学术和转化研究人员以及生物制药公司以匹配生物复杂性的分辨率和规模理解生物系统。Our products are behind breakthroughs in oncology, immunology, neuroscience and more, fueling powerful discoveries that are transforming the world's understanding of health and disease. To learn more, visit .我们的产品推动了肿瘤学、免疫学、神经科学等领域的突破，助力强大的发现，正在改变世界对健康和疾病的理解。欲了解更多信息，请访问 。10xgenomics.com10xgenomics.comor connect with us on或通过以下方式联系我们LinkedIn领英,，XX,，FacebookFacebook,，Bluesky蓝天空or或YouTubeYouTube.。Forward Looking Statements前瞻性声明This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are subject to the 'safe harbor' created by those sections.本新闻稿包含1995年《私人证券诉讼改革法案》所指的前瞻性陈述，该法案包含在经修订的1933年《证券法》第27A条和经修订的1934年《证券交易法》第21E条中，这些陈述受这些条款创建的“安全港”保护。All statements included in this press release, other than statements of historical facts, may be forward-looking statements. Forward-looking statements generally can be identified by the use of forward-looking terminology such as 'may,' 'might,' 'will,' 'should,' 'expect,' 'plan,' 'anticipate,' 'could,' 'intend,' 'target,' 'project,' 'contemplate,' 'believe,' 'see,' 'estimate,' 'predict,' 'potential,' 'would,' 'likely,' 'seek' or 'continue' or the negatives of these terms or variations of them or similar terminology, but the absence of these words does not mean that a statement is not forward-looking.本新闻稿中包含的所有声明，除历史事实陈述外，可能均为前瞻性声明。前瞻性声明通常可以通过使用前瞻性术语来识别，例如“可能”、“或许”、“将”、“应该”、“预期”、“计划”、“预计”、“能够”、“意图”、“目标”、“项目”、“考虑”、“相信”、“看到”、“估计”、“预测”、“潜力”、“会”、“很可能”、“寻求”或“继续”，或者这些术语的否定形式或其变体或类似术语。然而，这些词语的缺失并不意味着某个声明不是前瞻性的。These forward-looking statements include statements regarding litigation and the anticipated impacts of the settlement and license agreements with Bruker. These statements are based on management's current expectations, forecasts, beliefs, assumptions and information currently available to management.这些前瞻性陈述包括关于诉讼以及与布鲁克达成的和解和许可协议预期影响的陈述。这些陈述基于管理层的当前预期、预测、信念、假设以及目前可获得的信息。Actual outcomes and results could differ materially from these statements due to a number of factors and such statements should not be relied upon as representing 10x Genomics, Inc.'s views as of any date subsequent to the date of this press release. 10x Genomics, Inc. disclaims any obligation to update any forward-looking statements provided to reflect any change in 10x Genomics' expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law.由于多种因素，实际结果可能与这些声明存在重大差异，因此不应将此类声明视为代表10x Genomics, Inc.在本新闻稿发布日期之后的任何日期的观点。10x Genomics, Inc.不承担更新任何前瞻性声明的义务，以反映10x Genomics期望的任何变化或任何声明所基于的事件、条件或情况的任何变化，除非法律另有要求。The material risks and uncertainties t.材料风险和不确定性。March 31, 20252025年3月31日and 10-K for the fiscal year ended截至财政年度末的10-K表格December 31, 20242024年12月31日and elsewhere in the documents 10x Genomics, Inc. files with the Securities and Exchange Commission from time to time.在10x Genomics公司不时向证券交易委员会提交的文件及其他地方。Disclosure Information披露信息10x Genomics uses filings with the Securities and Exchange Commission, its website (10x Genomics 使用向证券交易委员会提交的文件及其网站 (https://www.10xgenomics.com/https://www.10xgenomics.com/), press releases, public conference calls, public webcasts and its social media accounts as means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.)，新闻稿、公开电话会议、公开网络广播及其社交媒体帐户作为披露重大非公开信息的手段，并遵守其在《公平披露规定》下的披露义务。Contacts联系人Investors:投资者：investors@10xgenomics.com投资者@10xgenomics.comMedia:媒体：media@10xgenomics.commedia@10xgenomics.comSOURCE 10x Genomics, Inc.来源：10x Genomics, Inc.WANT YOUR COMPANY'S NEWS想要你公司的新闻FEATURED ON PRNEWSWIRE.COM?刊登在PRNEWSWIRE.COM上？440k+44万+Newsrooms &新闻编辑室 &Influencers影响者9k+9k+Digital Media数字媒体Outlets插座270k+27万+Journalists记者Opted In已选择加入GET STARTED开始使用","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2535883768","isCrawlerRequest":true}